Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company Name/Scheme Genetic Signatures Limited (ASX: GSS) ABN/ARSN 30 095 913 205 1. Details of substantial holder (1)...
Becoming a substantial holder
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Notice of Extraordinary General Meeting
- GSS Investor Presentation - Proposed Merger with MAP
- GSS and MAP agree to Commercial Terms for Merger
- Receipt of Section 249D Notice from BCAL Diagnostics
- Date of AGM and Closing Date for Director Nominations
Later from Genetic Signatures
- Quarterly Activities/Appendix 4C Cash Flow Report
- 2026 Notice of Annual General Meeting
- GSS: Response to Media Speculation & BCAL letter to GSS
- Response to Media Speculation & BCAL letter to GSS
- Update on Commercial Terms for Proposed Merger with MAP
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures